Spectral Precise Image-Colon Cancer

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPhilips Clinical & Medical Affairs Global

About this trial

This is a single-center, comparative, observational study. Datasets will be collected from patients with pathologically confirmed colon cancer who undergo abdomen-pelvis enhanced spectral CT scan.

Eligibility criteria

Qualifiers

Patients pathologically confirmed with colon cancer via endoscopic biopsy.

Patients who underwent preoperative abdominopelvic enhanced spectral CT.

Study participant with age ≥ 18 years old.

Study participants that have signed Informed Consent Form (ICF).

Disqualifiers

The clinical data or pathological information is considered incomplete after evaluation by the investigator.

The investigator determined that poor image quality (e.g. obvious artifacts, missing critical scan layers) would not satisfy post-processing analysis.

Data of patients deemed inappropriate for inclusion after evaluation by the investigator.

Trial design

Treatments tested in this trial

  • This is an observational study

Treatment groups

No treatment groups listed

Sponsors and collaborators

Philips Clinical & Medical Affairs Global

Lead sponsor

Sun Yat-Sen University Cancer Center

Collaborator